ANI Pharmaceuticals has expanded its branded product portfolio by striking a deal to acquire several dermatology products from Sandoz in the US. The firm said the “accretive transaction” was “in line with the growth strategy laid out for the branded products business.”
The products acquired by ANI comprise: